Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,970 | 102 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $549.54 | 24 | $0 (2024) |
| Novo Nordisk Inc | $512.19 | 27 | $0 (2024) |
| PFIZER INC. | $178.82 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $139.66 | 8 | $0 (2024) |
| Lilly USA, LLC | $138.90 | 7 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $119.94 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $105.32 | 5 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $76.47 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $54.02 | 4 | $0 (2022) |
| Abbott Laboratories | $52.23 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $390.38 | 20 | Boehringer Ingelheim Pharmaceuticals, Inc. ($111.82) |
| 2023 | $277.79 | 14 | Lilly USA, LLC ($77.26) |
| 2022 | $489.14 | 25 | Novo Nordisk Inc ($160.12) |
| 2021 | $273.92 | 15 | Boehringer Ingelheim Pharmaceuticals, Inc. ($117.74) |
| 2020 | $127.23 | 7 | Novo Nordisk Inc ($50.16) |
| 2019 | $188.96 | 9 | Novo Nordisk Inc ($76.19) |
| 2018 | $182.12 | 10 | Novo Nordisk Inc ($93.45) |
| 2017 | $40.58 | 2 | Janssen Pharmaceuticals, Inc ($23.83) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: DIABETES | ||||||
| 11/26/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: VACCINES | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: VACCINES | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Cardio-renal | ||||||
| 09/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.76 | General |
| 09/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: DIABETES | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Respiratory | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: DIABETES | ||||||
| 05/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: DIABETES | ||||||
| 04/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: VACCINES | ||||||
| 03/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Gastroenterology | ||||||
| 03/19/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Diabetes | ||||||
| 02/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Diabetes | ||||||
| 01/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: VACCINES | ||||||
| 11/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Gastroenterology | ||||||
| 11/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.14 | General |
| 11/02/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: VACCINES | ||||||
| 09/18/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Diabetes | ||||||
| 08/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 258 | 347 | $71,800 | $24,306 |
| 2022 | 9 | 315 | 405 | $72,335 | $25,545 |
| 2021 | 9 | 348 | 441 | $61,870 | $24,388 |
| 2020 | 9 | 305 | 355 | $50,260 | $16,267 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 139 | $34,750 | $9,635 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 59 | $17,700 | $6,135 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $11,700 | $5,810 | 49.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 19 | 19 | $2,850 | $1,367 | 48.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $1,000 | $719.60 | 72.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 41 | 50 | $750.00 | $420.00 | 56.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 21 | $3,050 | $219.52 | 7.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 157 | $36,400 | $11,192 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 47 | 47 | $14,100 | $7,232 | 51.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 33 | $9,300 | $3,234 | 34.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 24 | 24 | $3,600 | $1,645 | 45.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 24 | $1,200 | $846.96 | 70.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 25 | 31 | $3,100 | $621.48 | 20.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 22 | 22 | $2,200 | $483.70 | 22.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 42 | 54 | $810.00 | $160.05 | 19.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 13 | $1,625 | $129.67 | 8.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 136 | $23,800 | $9,581 | 40.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 44 | 44 | $13,200 | $6,965 | 52.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 34 | $8,500 | $3,484 | 41.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 26 | 26 | $3,900 | $1,697 | 43.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 44 | 44 | $4,400 | $987.80 | 22.5% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 31 | 38 | $3,800 | $772.10 | 20.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 27 | 27 | $1,350 | $550.26 | 40.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 54 | 78 | $1,170 | $234.00 | 20.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 14 | $1,750 | $117.28 | 6.7% |
About Dr. Stanley John, M.D
Dr. Stanley John, M.D is a Internal Medicine healthcare provider based in Newburgh, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346272333.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stanley John, M.D has received a total of $1,970 in payments from pharmaceutical and medical device companies, with $390.38 received in 2024. These payments were reported across 102 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,970).
As a Medicare-enrolled provider, John has provided services to 1,226 Medicare beneficiaries, totaling 1,548 services with total Medicare billing of $90,506. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Newburgh, NY
- Active Since 07/07/2006
- Last Updated 03/03/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1346272333
Products in Payments
- JARDIANCE (Drug) $538.27
- Ozempic (Drug) $247.94
- XIFAXAN (Drug) $119.94
- FARXIGA (Drug) $106.56
- PREVNAR 20 (Biological) $105.40
- Kerendia (Drug) $76.47
- PREVNAR 13 (Biological) $73.42
- Victoza (Drug) $68.73
- XARELTO (Drug) $57.36
- INVOKANA (Drug) $47.96
- TRULICITY (Drug) $45.45
- EMGALITY (Drug) $40.69
- Tresiba (Drug) $39.26
- MOUNJARO (Drug) $37.89
- FREESTYLE LIBRE 2 (Device) $34.96
- Edarbi (Drug) $31.47
- JANUVIA (Drug) $26.94
- Rybelsus (Drug) $25.90
- AIRSUPRA (Drug) $18.23
- FreeStyle Libre 2 (Device) $17.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newburgh
Mohammed Allaw, M.d, M.D
Internal Medicine — Payments: $45,650
Dr. Maruthi Penumetsa, Md, MD
Internal Medicine — Payments: $42,696
Ward Neff, M.d, M.D
Internal Medicine — Payments: $9,402
Dr. Paul Feldman, Md, MD
Internal Medicine — Payments: $8,723
Uticia Belfield, M.d, M.D
Internal Medicine — Payments: $8,682
Dr. Manga Kodali, M.d, M.D
Internal Medicine — Payments: $6,603